Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677858 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL6518481 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL1263329 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL570722 | 0.96 | SOAT1 (0.35) | CA1CA2CA9SOAT1 | |
| SCHEMBL2260494 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL1420784 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL1537738 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL11793529 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL21049480 | 0.96 | CA1 (0.31) | CA1CA2CA9 | |
| Bicarbonate SCHEMBL20210820 | 0.96 | CA1 (0.42) | CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 702 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6410494-B1 | — | — | None | — | — | US | claimed |
| EP-4724101-A1 | TRANSDERMAL DELIVERY FORMULATIONS | Lifeactive, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260090981-A1 | TRANSDERMAL DELIVERY FORMULATIONS | LifeActive, Inc. (US) | 2026-04-02 | — | — | US | claimed |
| US-20260090982-A1 | TRANSDERMAL DELIVERY FORMULATIONS | LifeActive, Inc. (US) | 2026-04-02 | — | — | US | claimed |
| CN-119848475-B | Method for searching for carbonate type lead zinc ore | 昆明冶金研究院有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119848475-A | Method for searching for carbonate type lead zinc ore | 昆明冶金研究院有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119533749-A | Cement base material electrifying accelerating carbonization or mineralization system and method | 重庆交通大学 | 2025-02-28 | — | — | CN | claimed |
| WO-2024254228-A1 | TRANSDERMAL DELIVERY FORMULATIONS | LifeActive, Inc. (US) | 2024-12-12 | — | — | WO | claimed |
| CN-118771483-A | Small-granularity carbonic acid ternary positive electrode precursor material and synthesis method thereof | 苏州埃米特材料科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118644197-A | Intelligent management system for carbon emission monitoring in organization boundary | 广州创想碳汇技术有限公司 | 2024-09-13 | — | — | CN | claimed |
| US-6410494-B2 | Cleaning agent | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2002-06-25 | — | — | US | claimed |
| US-20010018407-A1 | Cleaning agent | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2001-08-30 | — | — | US | claimed |
| WO-2001057014-A2 | SYNTHESIS OF 3,6-DIALKYL-5,6-DIHYDRO-4-HYDROXY-PYRAN-2-ONE | F. HOFFMANN-LA ROCHE AG (CH) | 2001-08-09 | — | — | WO | claimed |
| EP-0638609-B1 | Biodegradable thermoformable materials made of starch esters | BUNA SOW LEUNA OLEFINVERB GMBH (DE) | 2001-03-21 | — | — | EP | claimed |
| US-5972245-A | USE AS STABILIZER IN A HALOGEN-CONTAINING RESIN COMPOSITION HAVING IMPROVED THERMAL STABILITY, INITIAL COLORING AND IMPROVED COLOR FASTNESS | CHEMSON POLYMER-ADDITIVE GESELLSCHAFT M.B.H. (AT) | 1999-10-26 | — | — | US | claimed |
| EP-0912708-A1 | TOILET CLEANSING BLOCK | S.C. Johnson & Son, Inc. (US) | 1999-05-06 | — | — | EP | claimed |
| EP-0812011-A2 | Cleaning agent | WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) | 1997-12-10 | — | — | EP | claimed |
| WO-1997044435-A1 | TOILET CLEANSING BLOCK | S. C. JOHNSON & SON, INC. (US) | 1997-11-27 | — | — | WO | claimed |
| US-5357027-A | Fireproof, heat resistant, impact resistant molding materials | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1994-10-18 | — | — | US | claimed |
| US-3972922-A | Process for preparing ether tricarboxylates | MONSANTO COMPANY (US) | 1976-08-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090981-A1 | TRANSDERMAL DELIVERY FORMULATIONS | CS, OAT, CKMT1A; CKMT1B | CA1 398/4885CA2 194/4885CA9 1700/4885 |
| US-20260090982-A1 | TRANSDERMAL DELIVERY FORMULATIONS | CS, OAT, CKMT1A; CKMT1B | CA1 398/4885CA2 194/4885CA9 1700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.